Φορτώνει......
Prior Treatment Time Affects Survival Outcomes in Metastatic Breast Cancer
PURPOSE: Sequential drug treatments in metastatic breast cancer (MBC) are disparate. Clinical trial data includes limited reporting of treatment context, primarily including the number of prior therapies. This study evaluates the relationship between prior treatment time, prior lines of treatment, a...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | JCO Clin Cancer Inform |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
American Society of Clinical Oncology
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7444642/ https://ncbi.nlm.nih.gov/pubmed/32479187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/CCI.20.00008 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|